Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Taverner WK"'
Autor:
Taverner, WK
Oncolytic viruses represent an emerging approach to cancer therapy. However, better understanding of their interaction with the host cancer cell and approaches to enhance their efficacy are needed. Efficient protein folding is essential for normal ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::ae15bfb41fa41bde0320b7ac7cd125e8
https://ora.ox.ac.uk/objects/uuid:35999485-a271-4941-bcc9-d251061ef83f
https://ora.ox.ac.uk/objects/uuid:35999485-a271-4941-bcc9-d251061ef83f
Autor:
Pokrovska TD; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Jacobus EJ; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Puliyadi R; Tumour Radiosensitivity Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Prevo R; Tumour Radiosensitivity Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Frost S; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Dyer A; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Baugh R; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Rodriguez-Berriguete G; Tumour Radiosensitivity Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Fisher K; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.; PsiOxus Therapeutics Ltd, Abingdon OX14 3YS, UK., Granata G; Tumour Radiosensitivity Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Herbert K; Tumour Radiosensitivity Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Taverner WK; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Champion BR; PsiOxus Therapeutics Ltd, Abingdon OX14 3YS, UK., Higgins GS; Tumour Radiosensitivity Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Seymour LW; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Lei-Rossmann J; Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Mar 26; Vol. 12 (4). Date of Electronic Publication: 2020 Mar 26.
Autor:
Scott EM; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Jacobus EJ; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Lyons B; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Frost S; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Freedman JD; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Dyer A; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Khalique H; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Taverner WK; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Carr A; Churchill Hospital, Oxford University Hospital NHS Trust, Oxford, OX3 7LE, UK., Champion BR; PsiOxus Therapeutics Ltd., Abingdon, OX14 3YS, UK., Fisher KD; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Seymour LW; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK. len.seymour@oncology.ox.ac.uk., Duffy MR; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Nov 21; Vol. 7 (1), pp. 320. Date of Electronic Publication: 2019 Nov 21.
Autor:
Taverner WK; Department of Oncology, University of Oxford, Roosevelt Drive, Oxford OX3 7DQ, UK., Jacobus EJ; Department of Oncology, University of Oxford, Roosevelt Drive, Oxford OX3 7DQ, UK., Christianson J; NDORMS, Botnar Research Centre, University of Oxford, Headington, Oxford OX3 7LD, UK., Champion B; PsiOxus Therapeutics, Ltd., Milton Park, Abingdon OX14 3YS, UK., Paton AW; Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide SA 5005, Australia., Paton JC; Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide SA 5005, Australia., Su W; Department of Oncology, University of Oxford, Roosevelt Drive, Oxford OX3 7DQ, UK., Cawood R; Oxford Genetics Ltd., Medawar Centre, Robert Robinson Avenue, Oxford OX4 4HG, UK., Seymour LW; Department of Oncology, University of Oxford, Roosevelt Drive, Oxford OX3 7DQ, UK., Lei-Rossmann J; Department of Oncology, University of Oxford, Roosevelt Drive, Oxford OX3 7DQ, UK.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2019 Sep 28; Vol. 15, pp. 117-130. Date of Electronic Publication: 2019 Sep 28 (Print Publication: 2019).
Autor:
Dyer A; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Baugh R; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Chia SL; Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia., Frost S; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Iris; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Jacobus EJ; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Khalique H; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Pokrovska TD; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Scott EM; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Taverner WK; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK., Seymour LW; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK. len.seymour@oncology.ox.ac.uk., Lei J; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK. janet.lei@oncology.ox.ac.uk.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2019 Mar; Vol. 26 (3-4), pp. 59-73. Date of Electronic Publication: 2018 Sep 04.
Autor:
Lei J; 0000 0004 1936 8948grid.4991.5Department of OncologyUniversity of Oxford OX3 7DQ Oxford UK janet.lei@oncology.ox.ac.uk., Jacobus EJ; 0000 0004 1936 8948grid.4991.5Department of OncologyUniversity of Oxford OX3 7DQ Oxford UK egon.jacobus@oncology.ox.ac.uk., Taverner WK; 0000 0004 1936 8948grid.4991.5Department of OncologyUniversity of Oxford OX3 7DQ Oxford UK william.taverner@dtc.ox.ac.uk., Fisher KD; 0000 0004 1936 8948grid.4991.5Department of OncologyUniversity of Oxford OX3 7DQ Oxford UK Kerry.fisher@oncology.ox.ac.uk., Hemmi S; 0000 0004 1937 0650grid.7400.3Institute of Molecular Life SciencesUniversity of Zurich Zurich Switzerland silvio.hemmi@imls.uzh.ch., West K; 0000 0004 0394 8673grid.476643.4PsiOxus Therapeutics Ltd PsiOxus House, 4-10 The Quadrant, Barton Lane OX14 3YS Abingdon Oxfordshire UK katy.west@psioxus.com., Slater L; 0000 0004 0394 8673grid.476643.4PsiOxus Therapeutics Ltd PsiOxus House, 4-10 The Quadrant, Barton Lane OX14 3YS Abingdon Oxfordshire UK Lorna.slater@psioxus.com., Lilley F; 0000 0004 0394 8673grid.476643.4PsiOxus Therapeutics Ltd PsiOxus House, 4-10 The Quadrant, Barton Lane OX14 3YS Abingdon Oxfordshire UK Fred.Lilley@psioxus.coms., Brown A; 0000 0004 0394 8673grid.476643.4PsiOxus Therapeutics Ltd PsiOxus House, 4-10 The Quadrant, Barton Lane OX14 3YS Abingdon Oxfordshire UK Alice.Brown@psioxus.com., Champion B; 0000 0004 0394 8673grid.476643.4PsiOxus Therapeutics Ltd PsiOxus House, 4-10 The Quadrant, Barton Lane OX14 3YS Abingdon Oxfordshire UK Brian.Champion@psioxus.com., Duffy MR; 0000 0004 1936 8948grid.4991.5Department of OncologyUniversity of Oxford OX3 7DQ Oxford UK Margaret.Duffy@oncology.ox.ac.uk., Seymour LW; 0000 0004 1936 8948grid.4991.5Department of OncologyUniversity of Oxford OX3 7DQ Oxford UK len.seymour@oncology.ox.ac.uk.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Jun 13; Vol. 6 (1), pp. 55. Date of Electronic Publication: 2018 Jun 13.